Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Benjamin Schuster-Böckler will join the Turing network for 2021-2022 to further his research in cancer big data.

The Alan Turing Institute is the national institute for data science and artificial intelligence. Turing researchers are based in universities and centres of research excellence across the UK and undertake interdisciplinary research of relevance to real-world problems.

Ludwig Oxford’s Dr Benjamin Schuster-Böckler will be a Turing Fellow for 2021-2022, joining the Turing’s vibrant, interdisciplinary, and collaborative research community. Ben’s research focuses on the causes and consequences of DNA mutations in cancer using computational genomics methods. This work will increase the understanding of how cancers develop and may provide insights into strategies for cancer prevention.

 

It gives me great pleasure to welcome this new group of Fellows. This cohort is incredibly multidisciplinary and diverse. They will bring a rich range of expertise and ensure we continue to do world-leading, impactful research - Adrian Smith, Turing Institute Director and Chief Executive.

Turing Fellows are ‘mid-to-senior career’ scholars with proven research excellence in data science, artificial intelligence, or a related field, whose research would be significantly enhanced through active involvement with the Turing network of universities and partners. The University of Oxford is one of the founding University partners and is eligible to nominate up to 35 fellows a year.

 

Similar stories

NDM prize studentships - apply now for October 2022 entry

Ludwig Oxford is currently recruiting exceptional students for fully funded four-year NDM prize DPhil studentships commencing in October 2022.

Developing a system to simultaneously detect genetic and epigenetic information

Dr Benjamin Schuster-Böckler wins funding to develop algorithms that can identify both genetic variation and DNA methylation from the same sequencing data, with applications in biomedical research and detection of diseases such as cancer.